Patents Assigned to ENOCHIAN BIOPHARMA, INC.
  • Methods and compositions using recombinant dendritic cells for cancer therapy
    Patent number: 11413338
    Abstract: Disclosed herein are methods and compositions for treating cancer by eliciting an immune response by administering dendritic cells expressing heterologous proteins. In some embodiments, a dendritic cell comprises one or more heterologous nucleic acid molecules encoding for CD40L and CXCL13. In some embodiments, the dendritic cell further comprises a heterologous nucleic acid molecule encoding for CD93. In yet additional embodiments, the dendritic cells expressing heterologous proteins are activated.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: August 16, 2022
    Assignee: ENOCHIAN BIOPHARMA, INC.
    Inventor: Serhat Gumrukcu